###begin article-title 0
Bone sialoprotein plays a functional role in bone formation and osteoclastogenesis
###end article-title 0
###begin p 1
###xml 30 52 30 52 <email xmlns:xlink="http://www.w3.org/1999/xlink">jane.aubin@utoronto.ca</email>
CORRESPONDENCE Jane E. Aubin: jane.aubin@utoronto.ca
###end p 1
###begin p 2
This article is distributed under the terms of an Attribution-Noncommercial-Share Alike-No Mirror Sites license for the first six months after the publication date (see ). After six months it is available under a Creative Commons License (Attribution-Noncommercial-Share Alike 3.0 Unported license, as described at ).
###end p 2
###begin p 3
###xml 143 146 143 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 287 290 287 290 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 474 477 472 475 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 496 499 494 497 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 870 873 868 871 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 917 920 915 918 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1040 1043 1038 1041 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1347 1350 1345 1348 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 148 152 <span type="species:ncbi:10090">mice</span>
###xml 291 295 <span type="species:ncbi:10090">mice</span>
###xml 383 387 <span type="species:ncbi:10090">mice</span>
###xml 478 482 <span type="species:ncbi:10090">mice</span>
###xml 500 504 <span type="species:ncbi:10090">mice</span>
###xml 1044 1048 <span type="species:ncbi:10090">mice</span>
###xml 1351 1355 <span type="species:ncbi:10090">mice</span>
Bone sialoprotein (BSP) and osteopontin (OPN) are both highly expressed in bone, but their functional specificities are unknown. OPN knockout (-/-) mice do not lose bone in a model of hindlimb disuse (tail suspension), showing the importance of OPN in bone remodeling. We report that BSP-/- mice are viable and breed normally, but their weight and size are lower than wild-type (WT) mice. Bone is undermineralized in fetuses and young adults, but not in older (>/=12 mo) BSP-/- mice. At 4 mo, BSP-/- mice display thinner cortical bones than WT, but greater trabecular bone volume with very low bone formation rate, which indicates reduced resorption, as confirmed by lower osteoclast surfaces. Although the frequency of total colonies and committed osteoblast colonies is the same, fewer mineralized colonies expressing decreased levels of osteoblast markers form in BSP-/- versus WT bone marrow stromal cultures. BSP-/- hematopoietic progenitors form fewer osteoclasts, but their resorptive activity on dentin is normal. Tail-suspended BSP-/- mice lose bone in hindlimbs, as expected. In conclusion, BSP deficiency impairs bone growth and mineralization, concomitant with dramatically reduced bone formation. It does not, however, prevent the bone loss resulting from loss of mechanical stimulation, a phenotype that is clearly different from OPN-/- mice.
###end p 3
###begin p 4
Abbreviations used: BFR, bone formation rate; BMD, bone mineral density; BSP, bone sialoprotein; DMP, dentin matrix protein; IBSP, integrin-binding sialoprotein; MEPE, matrix extracellular glycophosphoprotein; MLT, mineralization lag time; OPN, osteopontin; SIBLING, small, integrin-binding ligand N-linked glycoprotein; SPARC, secreted protein acidic and rich in cysteine; SPP, secreted phosphoprotein.
###end p 4
###begin p 5
###xml 80 81 80 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 405 406 405 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">2</xref>
###xml 502 503 502 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">3</xref>
###xml 505 506 505 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 736 737 736 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">5</xref>
###xml 906 907 906 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 921 922 921 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 972 973 972 973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 1157 1158 1157 1158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">9</xref>
###xml 1329 1330 1329 1330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 461 466 <span type="species:ncbi:9606">human</span>
###xml 481 486 <span type="species:ncbi:10090">mouse</span>
Proteins of the SIBLING (small, integrin-binding ligand N-linked glycoprotein) (1) family (osteopontin/secreted phosphoprotein-1 [OPN/SPP-1], bone sialoprotein/integrin-binding sialoprotein [BSP/IBSP], dentin sialophosphoprotein, dentin matrix protein-1 [DMP-1], and matrix extracellular glycophosphoprotein [MEPE]) comprise a structurally and phylogenetically homogeneous group of matricellular factors (2). Their genes are grouped as a "bone gene cluster" on human chromosome 4 (mouse chromosome 5) (3, 4), and they derive from a common ancestor shared with other enamel, milk, and saliva calcium-binding proteins, likely secreted protein acidic and rich in cysteine like-1 (SPARCL-1)/Hevin, which is a relative of SPARC/osteonectin (5). Although originally thought to be restricted to mineralized tissues, the SIBLINGs are now known to be expressed in other tissues and organs, such as salivary glands (6) and kidney (7). The multiple functions of OPN (for review see [8]), which is one of the earliest known and the best studied members of the family, range from inflammation to lactation and cancer, suggesting that it is best described as a cytokine (9). The SIBLINGs interact with cells, especially via integrins, and with bone mineral, and are thus in a key position to regulate bone development, remodeling, and repair (1).
###end p 5
###begin p 6
###xml 95 97 95 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 278 279 278 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 314 316 314 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 347 349 347 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 351 353 351 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 438 440 438 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 523 525 523 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 621 623 621 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 668 670 668 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 1109 1112 1109 1112 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1184 1187 1184 1187 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 528 532 <span type="species:ncbi:10090">Mice</span>
###xml 1074 1078 <span type="species:ncbi:10090">mice</span>
###xml 1188 1192 <span type="species:ncbi:10090">mice</span>
Although expression of DMP-1 and MEPE is restricted mainly to osteocytes, BSP (for review see [10]) and OPN have long been known to be highly expressed by osteoblasts, hypertrophic chondrocytes, and osteoclasts, where their functional roles are only beginning to be understood (1). In vitro data suggest that BSP (11), but not the ubiquitous OPN (11, 12), may initiate hydroxyapatite crystal formation in the bone matrix. Similar to OPN (13), BSP expression is increased in osteoblasts subjected to mechanical stimulation (14). Mice with the OPN gene ablated do not lose bone after mechanical unloading (tail suspension [15]) or upon estrogen withdrawal (ovariectomy [16]), showing the importance of OPN in the regulation of bone remodeling by osteoblasts and osteoclasts. These observations, together with their coexpression in osteogenic cells actively involved in bone deposition/remodeling, indicates the importance of establishing the functional specificities and degree of redundancy of OPN and BSP in the skeleton. To this end, we prepared and characterized knockout mice lacking expression of BSP (BSP-/-), whose phenotype and response to tail suspension are distinct from OPN-/- mice and other members of the SIBLING family.
###end p 6
###begin title 7
RESULTS
###end title 7
###begin title 8
###xml 3 6 3 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 7 11 <span type="species:ncbi:10090">mice</span>
BSP-/- mice are smaller and have shorter hypomineralized bones
###end title 8
###begin p 9
###xml 3 6 3 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 146 149 146 149 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 217 228 217 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, A&#8211;C</xref>
###xml 376 384 376 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 D</xref>
###xml 469 484 469 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, E and F</xref>
###xml 508 523 508 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, G and H</xref>
###xml 640 648 640 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 H</xref>
###xml 674 682 674 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 F</xref>
###xml 750 753 750 753 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 7 11 <span type="species:ncbi:10090">mice</span>
###xml 150 154 <span type="species:ncbi:10090">mice</span>
###xml 764 768 <span type="species:ncbi:10090">mice</span>
BSP-/- mice are viable and breed normally with a Mendelian ratio of genotypes in progeny. However, the weight and size of both male and female BSP-/- mice are lower than their WT counterparts at 4 mo and up to 16 mo (Fig. 1, A-C). This is independent of nutritional deficit, as indicated by the percentage of fat in body mass, which does not differ between the two genotypes (Fig. 1 D). Bone size parameters parallel the overall size measurements, with shorter femora (Fig. 1, E and F) and thinner cortices (Fig. 1, G and H) in 4-mo-old mutants. Although with age cortical thickness of mutant bones reaches a size equivalent to that of WT (Fig. 1 H), femur length does not (Fig. 1 F). No difference in growth plate thickness in adult (4-6 mo old) BSP-/- versus WT mice was detectable (unpublished data).
###end p 9
###begin p 10
###xml 42 45 42 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 0 51 0 51 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Morphology and skeletal morphometry of BSP<sup>&#8722;/&#8722;</sup> mice.</bold>
###xml 149 152 149 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 157 160 157 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 257 260 256 259 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 274 277 273 276 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 483 486 482 485 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 491 494 490 493 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 46 50 <span type="species:ncbi:10090">mice</span>
###xml 161 165 <span type="species:ncbi:10090">mice</span>
###xml 286 290 <span type="species:ncbi:10090">mice</span>
###xml 511 515 <span type="species:ncbi:10090">mice</span>
Morphology and skeletal morphometry of BSP-/- mice. Picture (A), measurements of body length (B), body weight (C), and percentage of fat mass (D) of +/+ and -/- mice. muCT scout images of whole femurs (E), and femur length (F) at 4 and 12 mo of age for WT (+/+) and mutant (-/-) female mice; similar results were obtained with males (not depicted). Two-dimensional images of midshaft sections in specimens from both genotypes (G) and cortical thickness (H) at 4 and 12 mo of age for +/+ and -/- male and female mice. Values are the mean +/- the SEM of 6-10 samples. **, P < 0.01; ****, P < 0.0001 versus matched WT; #, P < 0.05 versus matched females.
###end p 10
###begin p 11
###xml 296 297 295 296 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 330 333 317 320 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 495 502 470 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table I</xref>
###xml 640 642 615 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 669 672 644 647 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 47 51 <span type="species:ncbi:10090">mice</span>
###xml 76 80 <span type="species:ncbi:10090">mice</span>
###xml 121 125 <span type="species:ncbi:10090">mice</span>
###xml 334 338 <span type="species:ncbi:10090">mice</span>
###xml 696 700 <span type="species:ncbi:10090">mice</span>
Bone mineral density (BMD) of femurs of mutant mice is 20% lower than in WT mice at 4 mo of age, but equivalent in older mice (12 mo old; not depicted). Quantitative muCT analysis of midshaft femoral cortical bone showed that bone matrix mineralization (in milligrams of hydroxyapatite/centimeter3) is approximately9% lower in BSP-/- mice compared with WT animals at birth (embryonic day [E]18 fetuses), and approximately5% lower at 4 mo of age, but not significantly different at 12 mo of age (Table I). Quantitative microradiography (assessing the frequency distribution of mineral density on cortical and trabecular area of bone slices [17]) of a small sample of BSP-/- and WT male and female mice confirmed these findings (unpublished data).
###end p 11
###begin p 12
###xml 80 83 79 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 84 88 <span type="species:ncbi:10090">mice</span>
Tissue mineralization of cortical bone, measured by muCT in femurs of WT and BSP-/- mice
###end p 12
###begin p 13
Significant differences with WT are shown in bold.
###end p 13
###begin p 14
P < 0.01 versus matched WT.
###end p 14
###begin p 15
P < 0.01 versus matched sex.
###end p 15
###begin p 16
P < 0.001 versus matched WT.
###end p 16
###begin p 17
P < 0.001 versus matched sex.
###end p 17
###begin p 18
P < 0.05 versus matched sex.
###end p 18
###begin title 19
###xml 3 6 3 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 7 11 <span type="species:ncbi:10090">mice</span>
BSP-/- mice display high trabecular bone mass with low turnover
###end title 19
###begin p 20
###xml 50 65 50 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2, A and B</xref>
###xml 73 76 73 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 346 354 334 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl2">Table II</xref>
###xml 461 464 449 452 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 488 496 476 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 C</xref>
###xml 501 509 489 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl2">Table II</xref>
###xml 691 694 679 682 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 774 782 762 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 D</xref>
###xml 863 866 851 854 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 914 922 902 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 D</xref>
###xml 1058 1066 1046 1054 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 C</xref>
###xml 1198 1201 1186 1189 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1208 1216 1196 1204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 C</xref>
###xml 93 97 <span type="species:ncbi:10090">mice</span>
###xml 340 344 <span type="species:ncbi:10090">mice</span>
###xml 482 486 <span type="species:ncbi:10090">mice</span>
###xml 695 699 <span type="species:ncbi:10090">mice</span>
###xml 867 871 <span type="species:ncbi:10090">mice</span>
###xml 1202 1206 <span type="species:ncbi:10090">mice</span>
The trabecular bone volume (BV/TV) in long bones (Fig. 2, A and B) of BSP-/- male and female mice is approximately25-40% higher than in WT. This higher bone volume is associated with higher trabecular number (TbN) and lower trabecular separation (TbSp) in mutant versus WT bones, although trabecular thickness tends to be smaller in mutant mice (Table II). Double fluorochrome labeling revealed a very low bone formation activity in 4-mo-old male and female BSP-/- compared with WT mice (Fig. 2 C and Table II), both in terms of labeled surfaces (MS/BS) and apposition rate (MAR), resulting in a dramatically reduced bone formation rate (BFR). Low dynamic parameters of bone formation in BSP-/- mice correlate with reduced surfaces of cuboidal (plump) osteoblasts (Ob.S/BS; Fig. 2 D). In contrast, osteoid surface (OS/BS) and thickness (O.Th) are increased in BSP-/- mice, as well as mineralization lag time (MLT; Fig. 4 D), reflecting delayed primary mineralization. Osteoclast surfaces (Oc.S/BS) are reduced in mutant compared with WT femur of both sexes (Fig. 2 C). A similar phenotype is observed in tibia, where osteoclast numbers (N.Oc/B.Ar) were also found to be significantly reduced in BSP-/- mice (Fig. 2 C).
###end p 20
###begin p 21
###xml 3 6 3 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 0 72 0 72 <bold xmlns:xlink="http://www.w3.org/1999/xlink">BSP<sup>&#8722;/&#8722;</sup> mice have higher trabecular bone density and lower bone turnover.</bold>
###xml 130 133 130 133 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 143 146 143 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 277 280 276 279 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 285 288 284 287 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 444 447 443 446 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 452 455 451 454 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 578 581 577 580 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 586 589 585 588 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 712 715 709 712 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 7 11 <span type="species:ncbi:10090">mice</span>
###xml 148 152 <span type="species:ncbi:10090">mice</span>
###xml 414 418 <span type="species:ncbi:10090">mice</span>
###xml 465 469 <span type="species:ncbi:10090">mice</span>
###xml 597 601 <span type="species:ncbi:10090">mice</span>
###xml 649 653 <span type="species:ncbi:10090">mice</span>
BSP-/- mice have higher trabecular bone density and lower bone turnover. (A) Trabecular bone volume in tibias of 4-mo-old mutant (-/-) and WT (+/+) mice of either sex as measured by three-dimensional muCT. (B) Three-dimensional reconstruction and trichrome-stained sections of +/+ and -/- female femur. Bar, 0.5 mm. (C) Histomorphometric parameters of bone formation and resorption in the femur of male and female mice, and the tibia of female +/+ and -/- 4-mo-old mice. (D) Histomorphometric assessment of osteoblast surface and osteoid mineralization in the tibia of 4-mo-old +/+ and -/- female mice. All values are the mean +/- the SEM of 5 to 9 mice. *, P < 0.05; **, P < 0.01; ***, P < 0.001 versus matched +/+.
###end p 21
###begin p 22
###xml 99 102 99 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 103 107 <span type="species:ncbi:10090">mice</span>
Static and dynamic trabecular bone parameters in long bones of control and unloaded WT (WT) and BSP-/- mice
###end p 22
###begin p 23
See Materials and methods for details.
###end p 23
###begin p 24
muCT analysis on excised tibias.
###end p 24
###begin p 25
P < 0.0001 versus loaded control.
###end p 25
###begin p 26
Results are the mean +/- the SEM.
###end p 26
###begin p 27
P < 0.01 versus matched WT.
###end p 27
###begin p 28
P < 0.05 versus loaded control.
###end p 28
###begin p 29
P < 0.0001 versus matched WT.
###end p 29
###begin p 30
P < 0.001 versus matched WT.
###end p 30
###begin p 31
P < 0.01 versus loaded control.
###end p 31
###begin p 32
P < 0.001 versus loaded control.
###end p 32
###begin p 33
Histomorphometry on excised femurs.
###end p 33
###begin p 34
P < 0.05 versus matched WT.
###end p 34
###begin title 35
###xml 94 97 94 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
Both bone nodule mineralization and osteoclast differentiation are impaired in cultures of BSP-/- cells
###end title 35
###begin p 36
###xml 160 168 160 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 248 256 248 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 B</xref>
###xml 330 331 330 331 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 365 373 365 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 C</xref>
###xml 393 396 393 396 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 564 579 564 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3, A and D</xref>
###xml 690 705 690 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3, E and F</xref>
###xml 733 741 733 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 F</xref>
###xml 751 754 751 754 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 805 808 805 808 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 860 868 860 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 E</xref>
###xml 987 995 987 995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 G</xref>
###xml 1015 1023 1015 1023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 H</xref>
###xml 765 769 <span type="species:ncbi:10090">mice</span>
Total mesenchymal progenitor cell (total CFU-F) and osteoprogenitor frequency were assessed in WT and mutant male and female bone marrow stromal cell cultures (Fig. 3 A). In cultures from both sexes (males not depicted), the total number of CFU-F (Fig. 3 B) and the subset of putative osteoprogenitors (CFU-ALP = colonies with ALP+ cells, but unmineralized matrix; Fig. 3 C) is the same in BSP-/- and WT stromal cells, but the number of mature osteoblast colonies (CFU-O = colonies double-positive for ALP activity and mineral deposition) is dramatically reduced (Fig. 3, A and D). A significantly lower number of TRAP-positive cells and of multinucleated osteoclasts form in spleen cells (Fig. 3, E and F) and bone marrow cultures (Fig. 3 F) from BSP-/- versus WT mice. Although osteoclasts formed in BSP-/- cultures appear smaller than those in WT cultures (Fig. 3 E), when differentiated, osteoclasts were replated onto dentine slices. No significant difference in either the number (Fig. 3 G) or the mean area (Fig. 3 H) of resorption pits was observed between the two genotypes.
###end p 36
###begin p 37
###xml 111 114 111 114 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 0 121 0 121 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Impaired mineralized bone nodule formation and osteoclast differentiation, but not activity, in cultures of BSP<sup>&#8722;/&#8722;</sup> cells.</bold>
###xml 228 229 228 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 271 272 271 272 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 348 351 348 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 361 364 361 364 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 438 441 436 439 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 446 449 444 447 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 528 529 526 527 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 550 551 548 549 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 590 591 588 589 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 769 772 763 766 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 777 780 771 774 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 366 370 <span type="species:ncbi:10090">mice</span>
Impaired mineralized bone nodule formation and osteoclast differentiation, but not activity, in cultures of BSP-/- cells. Micrographs (A) and quantification of total colony forming units-fibroblasts (CFU-F; B), unmineralized ALP+ colonies (CFU-ALP; C) and mineralized ALP+ colonies (CFU-O; D) in bone marrow stromal cell cultures of female mutant (-/-) and WT (+/+) mice. Values are the mean +/- the SEM of 8-15 wells. (E) Micrographs of +/+ and -/- female spleen cells grown with RANKL+M-CSF and stained for TRAP activity (TRAP+); (F) number of TRAP+ cells; (G) number of osteoclasts (TRAP+ cells with >/=3 nuclei) formed in spleen cell and bone marrow cultures. Values are the mean +/- the SEM of 12 wells. (H) Number of resorption pits on dentine slices plated with +/+ and -/- differentiated osteoclasts; values are the mean +/- the SEM of six slices. ***, P < 0.001; ****, P < 0.0001 versus matched WT.
###end p 37
###begin title 38
###xml 3 6 3 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 7 11 <span type="species:ncbi:10090">mice</span>
BSP-/- mice express aberrant levels of osteoblast markers
###end title 38
###begin p 39
###xml 164 167 164 167 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 235 243 235 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 A</xref>
###xml 511 519 511 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 B</xref>
###xml 124 128 <span type="species:ncbi:10090">mice</span>
Expression of major osteoblast markers was assessed by quantitative RT-PCR of RNA from long bones of 4-mo-old mutant and WT mice; OPN expression is decreased in BSP-/- bones, whereas all other markers tested do not vary significantly (Fig. 4 A). Real-time PCR analysis of osteoblast marker expression in differentiating cultures showed higher levels of mRNAs for all markers in early cultures (day 13; day 17 for OPN), but reduced (osteocalcin) or delayed peak expression (all other markers) in later cultures (Fig. 4 B).
###end p 39
###begin p 40
###xml 0 77 0 77 <bold xmlns:xlink="http://www.w3.org/1999/xlink">In vivo and in vitro effects of BSP deletion on osteoblast marker expression.</bold>
###xml 333 336 329 332 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 337 341 <span type="species:ncbi:10090">mice</span>
###xml 382 386 <span type="species:ncbi:10090">mice</span>
###xml 652 656 <span type="species:ncbi:10090">mice</span>
In vivo and in vitro effects of BSP deletion on osteoblast marker expression. (A) Real-time PCR analysis of osteocalcin (OCN), OPN, tissue nonspecific alkaline phosphatase (ALP), type I collagen (COLL I), osterix (OSX), osteoprotegerin (OPG), and receptor-activator of NF-kappaB (RANKL) mRNA expression in femurs of 4-mo-old male BSP-/- mice. Values are the mean +/- the SEM of 3-4 mice (except for OSX) normalized to housekeeping gene L32 and expressed as the percentage of WT levels. (B) Time course of expression of COLL I, OCN, OSX, and OPN mRNA as assessed by real-time PCR in bone marrow cultures of WT (empty symbols) and mutant (black symbols) mice, grown in osteogenic conditions. Values were normalized to time-matched levels of the housekeeping gene L32. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001 versus matched WT.
###end p 40
###begin title 41
###xml 3 6 3 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 7 11 <span type="species:ncbi:10090">mice</span>
BSP-/- mice lose bone under conditions of unloading
###end title 41
###begin p 42
###xml 31 34 31 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 106 112 106 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 117 125 117 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl2">Table II</xref>
###xml 201 209 201 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl2">Table II</xref>
###xml 254 256 254 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 335 341 335 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 400 408 400 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl2">Table II</xref>
###xml 468 474 468 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 576 582 576 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 653 661 653 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl2">Table II</xref>
###xml 35 39 <span type="species:ncbi:10090">mice</span>
###xml 248 252 <span type="species:ncbi:10090">mice</span>
###xml 286 290 <span type="species:ncbi:10090">mice</span>
Both male and female WT and BSP-/- mice lose trabecular bone in the tibiae after 2 wk of tail suspension (Fig. 5 and Table II).Changes in BV/TV parallel other structural parameters of trabecular bone (Table II). As previously described in unloaded mice (18), trabecular bone loss in WT mice correlates with a dramatic decrease in BFR (Fig. 5) caused by a significant reduction of both MS/BS and MAR (Table II). BFR decrease upon unloading is detected in mutant males (Fig. 5). Osteoclast surface is also increased by hindlimb unloading in both genotypes, at least in females (Fig. 5), whereas osteoclast numbers show a nonsignificant trend to increase (Table II).
###end p 42
###begin p 43
###xml 3 6 3 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 0 37 0 37 <bold xmlns:xlink="http://www.w3.org/1999/xlink">BSP<sup>&#8722;/&#8722;</sup> mice lose bone upon unloading.</bold>
###xml 202 205 201 204 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 215 218 214 217 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 7 11 <span type="species:ncbi:10090">mice</span>
###xml 288 292 <span type="species:ncbi:10090">mice</span>
BSP-/- mice lose bone upon unloading. Three-dimensional muCT assessment of trabecular bone volume in tibia, and histomorphometric assessment of BFR and osteoclast surfaces (Oc.S/BS) in femur of mutant (-/-) and WT (+/+) control (CT) or 15-d tail-suspended (Unloaded, Uld) male and female mice. Values are the mean +/- the SEM of 7-9 samples. *, P < 0.05; **, P < 0.01; ***, P < 0.001 versus matched CT.
###end p 43
###begin title 44
DISCUSSION
###end title 44
###begin p 45
###xml 66 67 66 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">5</xref>
###xml 119 120 119 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 122 124 122 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
###xml 283 285 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 286 288 286 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 485 487 485 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 539 541 539 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 553 555 553 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 615 617 615 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 772 774 772 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 787 789 787 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">26</xref>
###xml 1042 1044 1042 1044 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">27</xref>
###xml 1065 1068 1065 1068 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1131 1133 1131 1133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">27</xref>
###xml 1135 1137 1135 1137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">28</xref>
###xml 1425 1427 1425 1427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">29</xref>
###xml 1429 1431 1429 1431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">30</xref>
###xml 1509 1512 1509 1512 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1568 1571 1568 1571 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1781 1788 1769 1776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table I</xref>
###xml 1930 1933 1918 1921 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 224 229 <span type="species:ncbi:10090">mouse</span>
###xml 879 883 <span type="species:ncbi:10090">mice</span>
###xml 1069 1073 <span type="species:ncbi:10090">mice</span>
###xml 1220 1224 <span type="species:ncbi:10090">mice</span>
###xml 1513 1517 <span type="species:ncbi:10090">mice</span>
###xml 1572 1576 <span type="species:ncbi:10090">mice</span>
The close phylogenic relationship between SIBLING family members (5), as well as their marked structural similarities (1, 19), raise questions about their functional specificities, especially in the context of bone. Indeed, mouse models in which particular SIBLINGs are knocked out (20-24) have displayed a variety of distinct phenotypes. For instance, both DMP1 and MEPE strongly regulate bone mineralization, but in opposite ways, with absence of the former leading to osteomalacia (23), at least in part through up-regulation of FGF23 (24) and MEPE (25), whereas absence of the latter results in high bone mass (22). Similarly, studies in vitro under carefully controlled conditions suggest that OPN is a strong inhibitor of hydroxyapatite crystal growth, whereas BSP (11) and DMP-1 (26) are promoters of mineralization. The recent characterization of OPN/ALP double-knockout mice, in which the osteomalacia caused by the lack of ALP activity is partly rescued by the absence of OPN, supports a role for OPN as a mineralization inhibitor (27). Interestingly, OPN-/- mice were also reported to have hypermineralized bone matrix (27, 28), in striking contrast to the hypomineralization that we document in BSP knockout mice. BSP was shown to be associated with bone acidic glycoprotein-75 and ALP in specific structures ("biomineralization foci") that are sites of mineral nucleation in the matrix of primary membrane bone (29, 30). The hypomineralization of bone nodules formed in cultures of cells from BSP-/- mice, the slight but significant mineral deficit in BSP-/- mice at birth (approximately9%), and the increased MLT in adult bone are compatible with a role of BSP in early bone matrix mineralization, whereas the progressive recovery with age of matrix mineral content (Table I) would suggest that this protein has no major and/or a redundant function in mature bone. However, the reduced expression of OPN in whole BSP-/- bones and the delayed peak of OPN in osteogenic mutant marrow cultures suggest a more complex situation in which down-regulation of OPN may be a compensatory response to loss of BSP, and more work is needed to establish the part played by each SIBLING family member in the development and regulation of matrix mineralization.
###end p 45
###begin p 46
###xml 373 375 373 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib31">31</xref>
###xml 452 454 452 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">32</xref>
###xml 455 457 455 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib36">36</xref>
###xml 566 568 566 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">37</xref>
###xml 569 571 569 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib40">40</xref>
###xml 654 657 654 657 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 658 662 <span type="species:ncbi:10090">mice</span>
Although the affinity of SIBLINGs for hydroxyapatite and the ability to regulate crystal growth/nucleation were among the earliest characteristics identified for members of this family, it is now clear that these proteins are involved in numerous other physiological processes. For example, recent investigations have implicated SIBLINGs in the regulation of MMP activity (31). This, together with their well-known capacity to mediate cell attachment (32-36), suggests that SIBLINGs are important factors in normal and pathogenic tissue remodeling, e.g., in cancer (37-40), and possibly in bone. The latter hypothesis is supported by the phenotype of BSP-/- mice.
###end p 46
###begin p 47
###xml 23 26 23 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 325 327 325 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib41">41</xref>
###xml 472 475 472 475 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 27 31 <span type="species:ncbi:10090">mice</span>
###xml 476 480 <span type="species:ncbi:10090">mice</span>
The shorter size of BSP-/- mice correlates with the reduced size of long bones. The complex process of endochondral ossification involves interplay between osteoblasts and chondrocytes, two BSP-expressing cell types (the latter at the hypertrophic stage), as well as vascularization, in which BSP may play a regulatory role (41). Detailed studies are being carried out to describe precisely at the tissue level the time course of skeletogenesis and long bone growth in BSP-/- mice, and clarify the cell types and mechanisms affected by BSP deletion.
###end p 47
###begin p 48
###xml 45 48 45 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 271 273 271 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib42">42</xref>
###xml 274 276 274 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib46">46</xref>
###xml 908 911 908 911 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1101 1103 1101 1103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib46">46</xref>
###xml 1343 1346 1343 1346 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 49 53 <span type="species:ncbi:10090">mice</span>
###xml 1347 1351 <span type="species:ncbi:10090">mice</span>
The reduced cortical thickness and BFR of BSP-/- mice are consistent with both the expression of BSP in actively bone forming/remodeling cells and its known and putative functions in cell attachment and tissue processing. Together with several previous in vitro studies (42-46), these results indicate that BSP is a potent regulator of osteoblast differentiation and/or activity. It is also notable that the absence of BSP does not appear to alter the total mesenchymal progenitor cell pool, osteoprogenitor recruitment, or early differentiation, as the total number of CFU-F and CFU-ALP is not detectably changed. However, the strikingly lower number of mineralized colonies indicates that BSP is required for late stages of (at least) primary osteogenesis. This is confirmed by RT-PCR results documenting an altered expression of late osteoblast markers, perhaps matrix-driven (low type I collagen), in BSP-/- marrow cultures, which is likely to impair the deposition of mineralized matrix. Our results are in agreement with recent data from osteoblasts treated with siRNA of intact and mutant BSP (46), which also indicate that the RGD-containing portion of the sequence is necessary for phenotypic regulation by BSP. These in vitro data are consistent with the low rate of bone formation observed in vivo, and thus the observation that BSP-/- mice actually display a higher trabecular bone mass strongly suggests that bone resorption is concomitantly reduced.
###end p 48
###begin p 49
###xml 411 413 411 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib47">47</xref>
###xml 437 439 437 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib48">48</xref>
###xml 644 647 644 647 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 899 901 892 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib47">47</xref>
###xml 903 905 896 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib49">49</xref>
###xml 995 998 988 991 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1005 1007 998 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib50">50</xref>
###xml 648 652 <span type="species:ncbi:10090">mice</span>
###xml 999 1003 <span type="species:ncbi:10090">mice</span>
It is notable that the loss of BSP does not affect osteoclast capacity to resorb normal (BSP-containing) dentine, suggesting that endogenous BSP production by osteoclasts is not required for resorption. On the other hand, absence of BSP does impair osteoclast differentiation in vitro, which is consistent with previous in vitro studies implicating BSP in regulation of osteoclast differentiation and activity (47), together with RANKL (48). That the same is true in vivo is supported by our observation that, whereas OPG and RANKL expression are normal, there is a reproducible reduction of the percentage of area covered by osteoclasts in BSP-/- mice, and a less consistent reduction in osteoclast numbers. Osteoclasts and their precursors adhere to BSP through the alphavbeta3 integrin receptor, and this interaction is thought to be an important regulator of their differentiation and activity (47, 49). It is thus possible that the differentiation of osteoclasts and, as is the case for OPN-/- mice (50), their resorptive activity in vivo (on matrix lacking BSP), is significantly impaired via an integrin outside-in pathway, but further studies will be necessary to clarify this point.
###end p 49
###begin p 50
###xml 29 32 29 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 75 78 75 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 205 207 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib50">50</xref>
###xml 244 247 244 247 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 349 351 349 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 506 508 506 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 840 843 840 843 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1135 1138 1135 1138 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1333 1336 1333 1336 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1854 1857 1854 1857 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1864 1866 1864 1866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib50">50</xref>
###xml 33 37 <span type="species:ncbi:10090">mice</span>
###xml 79 83 <span type="species:ncbi:10090">mice</span>
###xml 248 252 <span type="species:ncbi:10090">mice</span>
###xml 399 403 <span type="species:ncbi:10090">mice</span>
###xml 665 669 <span type="species:ncbi:10090">mice</span>
###xml 844 848 <span type="species:ncbi:10090">mice</span>
###xml 1139 1143 <span type="species:ncbi:10090">mice</span>
###xml 1337 1341 <span type="species:ncbi:10090">mice</span>
###xml 1858 1862 <span type="species:ncbi:10090">mice</span>
Overall, the phenotype of BSP-/- mice strikingly contrasts that seen in OPN-/- mice. The latter have a normal BFR, but a higher trabecular bone mass with increased numbers of poorly resorbing osteoclasts (50). Also, as previously mentioned, OPN-/- mice do not lose bone with hindlimb unloading, which is an established model of disuse osteoporosis (15). In contrast, and despite their low turnover, mice lacking BSP respond to hindlimb unloading by a significant trabecular bone loss. As previously shown (18), hindlimb unloading induces a transient increase of bone resorption followed by a more sustained inhibition of bone formation. After 15 d of unloading, WT mice show strongly reduced BFR with only a trend to increased osteoclast numbers and (in females) surfaces in our experiments, indicative of a late-stage bone response. In BSP-/- mice, BFR reduction is observed only in males, whereas the increased osteoclast surface is seen only in females, likely caused by distinct kinetics between the two sexes. Collectively, our data suggest that osteoblastic formation and osteoclastic resorption are modulated by unloading in BSP-/- mice, the latter likely accounting for most of the bone loss, given the low BFR. Although, as mentioned, our in vitro results on dentin cannot discount reduced in vivo osteoclast activity in BSP-/- mice, older mutant animals do lose trabecular bone (not depicted), which is suggestive of efficient metaphyseal resorption in mature (>5-mo-old) animals. Collectively, these results suggests that BSP is not an absolute limiting factor for increased resorption, perhaps caused by some compensatory mechanisms, such as overexpression of related proteins (possibly another SIBLING) in challenging conditions. Whatever the compensatory mechanism, it contrasts with the cell autonomous defect in osteoclast activity of OPN-/- mice (50), and stresses that the cellular mechanisms underlying the two phenotypes are quite different.
###end p 50
###begin p 51
###xml 18 21 18 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 22 26 <span type="species:ncbi:10090">mice</span>
In conclusion, BSP-/- mice display a reduced body and long bone growth, but have a high trabecular bone mass accompanied by low bone turnover that is, nonetheless, responsive to mechanical challenges. Our data thus highlight the specificity of BSP roles in the bone context and further confirm the nonredundancy of function of SIBLING family members in skeletal biology.
###end p 51
###begin title 52
MATERIALS AND METHODS
###end title 52
###begin title 53
###xml 20 23 20 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bsp</italic>
###xml 59 64 <span type="species:ncbi:10090">mouse</span>
Construction of the bsp-null targeting vector and chimeric mouse production.
###end title 53
###begin p 54
###xml 4 7 4 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bsp</italic>
###xml 182 185 165 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bsp</italic>
###xml 240 243 223 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bsp</italic>
###xml 408 411 391 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bsp</italic>
###xml 649 657 632 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 A</xref>
###xml 815 817 798 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib51">51</xref>
###xml 941 943 924 926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib52">52</xref>
###xml 1292 1300 1273 1281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 B</xref>
###xml 1637 1640 1618 1621 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1753 1761 1734 1742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 C</xref>
###xml 8 13 <span type="species:ncbi:10090">mouse</span>
###xml 56 61 <span type="species:ncbi:10090">mouse</span>
###xml 660 665 <span type="species:ncbi:10090">Mouse</span>
###xml 1346 1350 <span type="species:ncbi:10090">mice</span>
###xml 1641 1645 <span type="species:ncbi:10090">mice</span>
###xml 1747 1751 <span type="species:ncbi:10090">mice</span>
Two bsp mouse cDNA clones were used to screen a 129Sv/J mouse genomic lambdaDASH2 phage library. 2 overlapping genomic clones, spanning approximately19 kb of sequence and the entire bsp locus, were isolated and sequenced. A short 5' arm of bsp homology on a 600-bp Sac1 fragment downstream of exon I was cloned upstream of the PGKneo cassette in the pPNT positive-negative selection vector. A long 3' arm of bsp homology on a 6-kb Kpn fragment was then cloned downstream of the PGKneo cassette, giving the final targeting vector. Homologous recombination resulted in the deletion of exons II-III and insertion of the PGKneo cassette in their place (Fig. 6 A). Mouse embryonic stem cells (R1; passage 8) were provided by A. Nagy (Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada) (51). Propagation, electroporation, and selection of recombinant R1 clones were performed essentially as previously described (52). In brief, RI embryonic stem cells were electroporated with the NotI linearized targeting vector and were selected by using 200 mug of active Geneticin (G418; Invitrogen)/ml and 2 muM ganciclovir (Syntex, Inc.). DNA from selected clones was digested with HindIII and analyzed by Southern blot hybridization using a HindIII/Xba probe as indicated (Fig. 6 B). Positive clones were used to make chimeric mice, among which a male transmitted the mutation through the germ line after crossing with albino CD1 outbred females. Offspring were maintained on a 129/CD-1 background and genotyped by Southern blotting. Northern blotting of total RNA extracted from calvariae and long bones of WT and BSP-/- mice, with the ribosomal protein L32 as a control, confirmed the total lack of BSP expression in knockout mice (Fig. 6 C).
###end p 54
###begin p 55
###xml 29 32 29 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bsp</italic>
###xml 0 38 0 38 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Strategy for deletion of the <italic>bsp</italic> gene.</bold>
###xml 231 234 231 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 251 254 251 254 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 270 273 270 273 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 521 524 521 524 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 529 532 529 532 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 275 280 <span type="species:ncbi:10090">mouse</span>
###xml 533 537 <span type="species:ncbi:10090">mice</span>
Strategy for deletion of the bsp gene. (A) A schematic representation of the WT and mutant alleles and the targeting vector. E, EcoRI; H, HindIII; B, BamHI; X, XbaI; N, NotI; K, Kpn. (B) Southern blot analysis of tail DNA from WT (+/+), heterozygote (+/-) and knockout (-/-) mouse littermates. The presence of the 3.2-kb wild-type fragment and the 4.8-kb recombinant fragments are seen in genomic DNA digested with HindIII. (C) Northern blot analysis of BSP mRNA expression in calvaria and femur bones of young and adult +/+ and -/- mice. L32, housekeeping gene.
###end p 55
###begin title 56
Care of animals and sampling procedures.
###end title 56
###begin p 57
The procedures for the care and killing of the animals were in accordance with the University of Toronto Animal Care Committee and the European Community standards on the care and use of laboratory animals (Ministere de l'Agriculture, France; Authorization 04827). The animal experiments were approved by the local Animal Care Committees. During acclimatization and experimentation, the animals were kept in standard conditions of temperature (23 +/- 2degreesC) and light-controlled environment (12 h light/12 h dark cycle), and with free access to water and pelleted food (UAR rodent diet No.R03-25; UAR).
###end p 57
###begin title 58
Measurement of body and skeletal parameters.
###end title 58
###begin p 59
###xml 15 20 <span type="species:ncbi:10090">mouse</span>
After killing, mouse body length was measured from the nose to the tip of the tail. Biphotonic densitometry was used to measure BMD (Hologic QDR 1500) and fat mass (Piximus; Lunar Corp.). Femur length was measured on isolated bones with a 1/50 caliper between the olecranon and the articular condyle of the knee.
###end p 59
###begin title 60
Hindlimb unloading.
###end title 60
###begin p 61
###xml 29 32 29 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 134 135 134 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 40 44 <span type="species:ncbi:10090">mice</span>
16-wk-old male and female BSP-/- and WT mice were either subjected to hindlimb unloading through tail suspension or kept unsuspended (n = 10 per treatment group) for 15 d. Each suspended and control animal was single-housed in a polycarbonate cage (26x15x14 cm); suspended cages were raised by a frame supporting the suspension hanging system. Tail suspension experiments were performed with standard housing conditions as above. After sacrifice, the long bones were dissected out and processed for histomorphometry and/or muCT, as described in these sections.
###end p 61
###begin title 62
Histology and histomorphometry.
###end title 62
###begin p 63
###xml 1515 1516 1514 1515 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 1556 1558 1555 1557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 205 209 <span type="species:ncbi:10090">Mice</span>
###xml 1461 1465 <span type="species:ncbi:10090">mice</span>
Fetuses at term (E18) and bones from adult specimens were processed undecalcified for histology. 6 and 2 d before death, adult animals were labeled with 25 mg/kg tetracycline by intraperitoneal injection. Mice were killed by cervical dislocation, and long bones were dissected out and fixed in 3.7% paraformaldehyde in PBS. Fetuses were fixed and dehydrated in the same way. Undecalcified bone samples were embedded in methylmethacrylate, and longitudinal coronal slices were cut with a Jung model K microtome (Reichert-Jung) and used for modified Goldner staining, tartrate-resistant acid phosphatase (TRAP) staining (without counterstaining) of osteoclasts, or left unstained. Trabecular bone volume (BV/TV), osteoblast surface (Ob.S/BS), osteoid surface (OS/BS), and thickness (O.Th) were measured on Goldner-stained sections. Dynamic bone remodeling parameters were measured by histomorphometry after double-tetracyclin labeling (on unstained sections for labeled surfaces [MS/BS], mineral apposition rate [MAR], and BFR [BFR/BS]). These parameters were combined to assess osteoid mineralization through MLT (MLT = [O.Th x OS]/[MS x MAR]) and Osteoid Maturation Time (OMT = O.Th/MAR). Osteoclast surfaces (Oc.S/BS) and numbers (N.Oc/B.Ar) were measured on TRAP-stained sections. Fetus sections were stained with von Kossa for mineral or toluidine blue for cartilage. Quantitative microradiography was done on 100-mum-thick sections of tibiae from 10-mo-old mice, and bone matrix mineralization (grams/centimeter3) was measured as previously described (17).
###end p 63
###begin title 64
High-resolution muCT.
###end title 64
###begin p 65
###xml 1287 1289 1285 1287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib53">53</xref>
###xml 100 104 <span type="species:ncbi:10090">mice</span>
###xml 255 259 <span type="species:ncbi:10090">mice</span>
Fetuses at term (E18), fixed and ethanol-dehydrated bones dissected from adult specimens, and whole mice were scanned with a high-resolution muCT (Viva CT40; Scanco Medical). Fetuses and isolated bones were kept in ethanol during image acquisition. Whole mice were killed by cervical dislocation before scanning. Data were acquired at 55 KeV for adults and 45 KeV for fetuses, with 10 mum cubic resolution. Three-dimensional reconstructions were generated with the following parameters: Sigma, 1.2; Support, 2; Threshold, 160 (spongiosa) or 280 (cortex) for adult samples and Threshold, 140 for fetuses. Cortical thickness and tissue mineral density were calculated by integration of the value on each transverse section of a set of 100 chosen in the midshaft area. Tissue mineral density was derived from the linear attenuation coefficient of thresholded bone through precalibration of the apparatus for the acquisition voltage chosen. The bone volume fraction of trabecular metaphysis (VOX BV/TV) was measured on a set of 80 sections under the growth plate, within the secondary spongiosa. Trabecular thickness (Tb.Th), trabecular number (Tb.N), trabecular separation (Tb.Sp), and structure model index (SMI) were calculated without assuming a constant model, as previously described (53). SMI estimates the plate-rod characteristics of a structure; its value is 0 for an ideal plate, and 3 for an ideal rod, with intermediate values reflecting the volume ratio between rods and plates.
###end p 65
###begin title 66
In vitro osteoblast and osteoclast differentiation and activity assays.
###end title 66
###begin p 67
###xml 461 463 461 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib54">54</xref>
###xml 465 467 465 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib55">55</xref>
###xml 521 524 521 524 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 888 889 878 879 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 1186 1188 1172 1174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib54">54</xref>
###xml 1190 1192 1176 1178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib55">55</xref>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 532 536 <span type="species:ncbi:10090">mice</span>
Mouse bone marrow stromal cell cultures were used to quantify the total number of progenitors: total colony forming units-fibroblasts (CFU-F; methylene blue-positive colonies), colony forming units-tissue nonspecific alkaline phosphatase (CFU-ALP, i.e., putative osteoprogenitors expressing ALP), and definitive osteoblastic cells with mature osteoblasts and mineralized matrix (CFU-O; ALP and von Kossa-positive, mineralized colonies) as previously described (54, 55). In brief, young (2-4 mo of age) male and female BSP-/- and WT mice were killed by cervical dislocation, and the marrow was flushed from dissected femurs in alpha-minimum essential medium (alphaMEM) with antibiotics (100 mug/ml penicillin G [Sigma-Aldrich], 50 mug/ml gentamycin [Sigma-Aldrich], and 300 ng/ml fungizone [Flow Laboratories]) containing 15% heat-inactivated FCS. Recovered cells were plated at 0.5-1 x 106 nucleated cells/35-mm dish and cultured in the same medium, which was supplemented additionally with ascorbic acid (50 mug/ml) and beta-glycerophosphate (10 mM). Cultures were maintained for 18-21 d; fixing, staining, and quantification of colony numbers was carried out as previously described (54, 55).
###end p 67
###begin p 68
###xml 42 45 42 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 325 326 325 326 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4</sup>
###xml 467 468 467 468 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 487 488 487 488 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 580 582 576 578 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;8</sup>
###xml 888 889 878 879 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1282 1284 1270 1272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib56">56</xref>
###xml 60 64 <span type="species:ncbi:10090">mice</span>
For osteoclast differentiation assays, BSP-/- and WT female mice were killed by cervical dislocation. Spleens were removed and osteoclast precursors were isolated by centrifugation using Lympholyte cell separation media (CL 5030; Cedarlane Laboratories) for 20 min at 2,500 rpm. Cells were plated in 24-well plates at 25 x 104 cells per well, in differentiation medium containing 50 ng/ml RANKL and 20 ng/ml MCSF (Peprotech). Bone marrow was collected, plated (2 x 106 nucleated cells/cm2), and grown as described in the previous paragraph in alphaMEM, 15%FCS supplemented with 10-8 M 1, and 25-dihydroxy vitamin D (Sigma-Aldrich). At day 7 of the culture, cells were fixed with 2% paraformaldehyde, washed with PBS, and incubated with a mixture of 2 mg/ml Naphtol AS-TR Phosphate (Sigma-Aldrich) and 5 mg/ml Fast Violet B Salt (Sigma-Aldrich) for 1 h at 40degreesC. TRAP-expressing (TRAP+) cells were counted under a light microscope, and cells with >/=3 nuclei were considered as multinucleated osteoclasts. For resorption pit assay, equal numbers of mature osteoclasts from spleen cell cultures were plated on dentine slices (provided by N. Takahashi, Matsumoto Dental University, Nagano, Japan) for 48 h, and resorption pits were stained with toluidine blue after cell removal (56).
###end p 68
###begin title 69
Real-time RT-PCR.
###end title 69
###begin p 70
###xml 546 548 546 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib57">57</xref>
###xml 626 627 626 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 627 628 627 628 <sub xmlns:xlink="http://www.w3.org/1999/xlink">T</sub>
###xml 765 767 765 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib58">58</xref>
###xml 795 804 795 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl3">Table III</xref>
Total RNA was isolated from midshaft femoral cortical bone (4-mo-old males) or from cell cultures using TRI Reagent according to the manufacturer's instructions (Sigma-Aldrich). Samples were reverse transcribed, and 50 ng of the cDNA (RNA equivalent) was amplified through RT-PCR using the SYBR Green PCR Master Mix (Applied Biosystems) on the MyIQ single-color real-time PCR detection system (Bio-Rad Laboratories). The raw, background-subtracted fluorescence data provided in the MyIQ software were analyzed by the real-time PCR Miner program (57). The resulting PCR efficiency and fractional cycle number of the threshold (CT) were used for transcript quantification. mRNA expression was normalized to L32 mRNA. PCR primer sequences were chosen from PrimerBank (58), unless otherwise stated (Table III), and were verified to span introns.
###end p 70
###begin p 71
PCR primers in 5'-3' direction
###end p 71
###begin p 72
NA, not available.
###end p 72
###begin p 73
F, forward; R, reverse.
###end p 73
###begin p 74
Designed with Primer Express software, version 2.0 (PerkinElmer).
###end p 74
###begin title 75
Statistical analysis.
###end title 75
###begin p 76
###xml 171 172 170 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">U</italic>
###xml 191 192 190 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 270 271 269 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
Phenotypic evaluation (morphometry, histomorphometry, muCT, densitometry, and microradiography) data, as well as in vitro experiments, were assessed with the Mann-Whitney U test or Student's t test (stromal cell colony counts). RT-PCR results were analyzed by Student's t test. Tail suspension experiments were analyzed by two-way ANOVA with post test.
###end p 76
###begin p 77
The authors thank Dr. N. Takahashi for the generous gift of dentine slices, Dr. A. Gupta for help with BSP gene sequencing and the Laboratoire de Transgenese, Service Commun de l'Universite de Bordeaux II, especially P. Costet and U. Bhargava (Toronto), for the care of animals.
###end p 77
###begin p 78
This work was funded by the Canadian Institutes of Health Research (FRN83704 to J.E. Aubin) and by the Institut National de la Sante et de la Recherche Medicale (INSERM) and the Centre National de la Recherche Scientifique (CNRS), through both basal funding to affiliated laboratories and a collective grant within the Ingenierie Tissulaire-Biomecanique-Biomateriaux (IT2B) INSERM/CNRS cooperative program (to L. Malaval, M.-H. Lafage-Proust, J. Amedee, and L. Vico).
###end p 78
###begin p 79
The authors have no conflicting financial interests.
###end p 79

